HIV and AIDS Trial, Recruiting (NCT06762054)

HIV and AIDS Trial, Recruiting NCT06762054 Sponsor: University of Nairobi Condition: HIV and AIDS

Printed from Voxsanity (voxsanity.com.au) — NCT06762054 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Hiv Aids

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who are able and willing to give their consent to take part (for those under 18, a parent or legal guardian must also give consent)
People aged 1 year or older
People who have a confirmed HIV-1 diagnosis, confirmed using national HIV testing standards at the study site
People who have been taking a DTG-based HIV treatment regimen for at least six months
People whose most recent HIV-1 viral load test (taken within the last 3 months, and after at least 6 months on their current treatment) showed 1,000 or more copies per millilitre of blood

Who may not be able to join:

People who have changed their HIV treatment regimen due to confirmed or suspected treatment failure while on a PI- or INSTI-based regimen
People who, in the opinion of the trial investigator, have a reason that would make it very difficult to have their viral load monitored during the trial — for example, plans to move away from the trial site area, or a serious decline in health (confirm with trial site)
People who are currently taking an NNRTI or PI medication alongside DTG

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 8 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Loice A Ombajo, MMed, MSc, University of Nairobi

Phone: +254737223988

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06762054

Sponsor: University of Nairobi

Phase: Not Applicable

Status: Recruiting

Condition: HIV and AIDS

Trial contact: +254737223988

More information: https://clinicaltrials.gov/study/NCT06762054

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who are able and willing to give their consent to take part (for those under 18, a parent or legal guardian must also give consent)
People aged 1 year or older
People who have a confirmed HIV-1 diagnosis, confirmed using national HIV testing standards at the study site
People who have been taking a DTG-based HIV treatment regimen for at least six months
People whose most recent HIV-1 viral load test (taken within the last 3 months, and after at least 6 months on their current treatment) showed 1,000 or more copies per millilitre of blood

Who may not be able to join:

People who have changed their HIV treatment regimen due to confirmed or suspected treatment failure while on a PI- or INSTI-based regimen
People who, in the opinion of the trial investigator, have a reason that would make it very difficult to have their viral load monitored during the trial — for example, plans to move away from the trial site area, or a serious decline in health (confirm with trial site)
People who are currently taking an NNRTI or PI medication alongside DTG

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 8 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University of Nairobi

Registry

ClinicalTrials.gov

Start date

3 March 2025

Est. completion

1 October 2026

Where this trial is recruiting

Kenya Lesotho Mozambique Tanzania

Primary endpoints

Viral suppression rate

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 8 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov